Purchase Order 75D30123P16470
Award Date
4/27/23
Potential Completion Date
7/20/24
Potential Value
$14K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anchorage, AK 99508, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a maintenance agreement with a total ceiling value of $75,716.00 and a period of performance through June 10, 2021. The contract does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies such as the...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $12,944.40, is for the maintenance of Illumina equipment. It does not have a set-aside designation. Illumina has a history of providing a range of genomic sequencing systems, reagents, and support services to various federal agencies, including the...
This is a federal purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $113,260.75 and is for the delivery of laboratory equipment. The contract is for a firm fixed price and has an ultimate completion date of August 31, 2017. There is no set-aside designation mentioned. Illumina has previously been awarded prime contracts and...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $223,532.40, is for the maintenance and services of Illumina sequencing instruments. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...
This is a firm fixed price purchase order service agreement awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The contract has a ceiling value of $236,726.60 and a period of performance through August 31, 2025. It does not have a set-aside designation. The contract provides for Illumina to furnish genomic sequencing goods and services, likely building on...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The contract is for the maintenance, repair, and support of Illumina's NovaSeq 6000 and MiSeq sequencing instruments over a 2-year period, with a ceiling value of $139,336.76. This contract does not have a set-aside designation. Illumina has previously received prime federal contracts and...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the supply of lab supplies. The contract has a ceiling value of $97,152 and runs through February 28, 2017. The contract is not set aside for any special business designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. Through past federal contract awards, Illumina has provided a range of...